Intech Investment Management LLC raised its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 179.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,124 shares of the company's stock after acquiring an additional 27,045 shares during the quarter. Intech Investment Management LLC owned approximately 0.07% of Astrana Health worth $1,328,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ASTH. Handelsbanken Fonder AB grew its position in shares of Astrana Health by 4.7% in the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock valued at $281,000 after purchasing an additional 400 shares during the last quarter. Swiss National Bank increased its position in Astrana Health by 1.1% during the fourth quarter. Swiss National Bank now owns 88,444 shares of the company's stock worth $2,789,000 after buying an additional 1,000 shares in the last quarter. KBC Group NV acquired a new position in shares of Astrana Health in the third quarter worth $70,000. Quarry LP purchased a new stake in shares of Astrana Health in the third quarter valued at $77,000. Finally, Moran Wealth Management LLC boosted its stake in shares of Astrana Health by 21.5% during the fourth quarter. Moran Wealth Management LLC now owns 7,944 shares of the company's stock valued at $250,000 after acquiring an additional 1,404 shares during the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.
Astrana Health Trading Up 2.1 %
Shares of ASTH stock traded up $0.64 during mid-day trading on Monday, reaching $31.53. The company's stock had a trading volume of 97,351 shares, compared to its average volume of 254,542. The company's 50 day simple moving average is $33.97 and its 200-day simple moving average is $42.49. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a 12-month low of $23.12 and a 12-month high of $63.20. The firm has a market capitalization of $1.58 billion, a PE ratio of 24.20, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30.
Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $665.21 million for the quarter, compared to analyst estimates of $617.24 million. On average, research analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.
Analyst Ratings Changes
A number of equities research analysts have recently commented on the stock. Macquarie upgraded shares of Astrana Health to a "hold" rating in a report on Monday, December 16th. Bank of America decreased their price target on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a research note on Tuesday, March 4th. Truist Financial dropped their price objective on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research note on Tuesday, March 18th. Stifel Nicolaus lowered their target price on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a report on Thursday, February 20th. Finally, Robert W. Baird cut their price target on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Two equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Astrana Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $56.17.
Check Out Our Latest Stock Analysis on ASTH
Astrana Health Profile
(
Free Report)
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Read More
Before you consider Astrana Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.
While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
